This article is for informational and educational purposes only and does not constitute medical advice. Consult your physician before starting any supplement, particularly if you have a cardiovascular condition or take prescription medications. UTCardiothoracicSurgery.com Editorial Team | July 2026. This article may contain affiliate links. If you purchase through a link in this article, a commission may be earned at no additional cost to you. This does not affect the objectivity of the information presented. FTC disclosure required by 16 C.F.R. Part 255.
Quick Answer: Presgera is a nerve health supplement containing Alpha-Lipoic Acid, CoQ10, and Magnesium Glycinate marketed for neuropathy-related discomfort. While individual ingredients have research support for nerve function, the proprietary blend structure prevents dose verification against clinical thresholds. Cardiac patients should be aware that CoQ10 may interact with warfarin and blood pressure medications, and ALA can affect blood sugar levels in patients on diabetes medications often prescribed alongside cardiovascular drugs.
Why This Review Exists: The Cardiac Safety Gap
Neuropathy supplements occupy a unique intersection with cardiovascular care. Many individuals experiencing peripheral neuropathy are simultaneously managing diabetes, hypertension, or heart failure — conditions requiring medications that can interact with common nerve health ingredients. Most Presgera reviews evaluate the product purely for nerve relief without addressing how its ingredients behave alongside cardiac drug regimens. The UTCTS Health Review Desk examined Presgera specifically through a cardiovascular safety lens because the overlap between neuropathy patients and cardiac patients is substantial. Diabetic neuropathy alone accounts for the majority of peripheral neuropathy cases in the United States, and these patients frequently take statins, ACE inhibitors, beta-blockers, and anticoagulants concurrently. This review addresses the questions a cardiologist's patient should ask before adding Presgera to an existing medication regimen.
Verified Product Summary: What the Label Shows
Presgera is a capsule-form dietary supplement marketed for the “Trinity of Nerve Discomfort” — targeting relief from nerve discomfort, promoting nerve function, and addressing inflammation. The supplement is manufactured following dietary supplement quality standards and distributed through the manufacturer's official website. The label confirms inclusion of Alpha-Lipoic Acid (ALA), Coenzyme Q10 (CoQ10), and Magnesium Glycinate. Additional ingredients are described as part of a proprietary blend supporting complementary nerve health mechanisms. The manufacturer offers a 60-day money-back guarantee on the most recent order. Serving size and specific dosing instructions should be verified on the current product label, as formulations may change without notice.
The Label vs. Marketing Analysis
The UTCTS review team identified several discrepancies worth noting. Presgera's marketing emphasizes a comprehensive, multi-mechanism approach to nerve health — oxidative stress reduction, energy support, mineral supplementation, and anti-inflammatory effects. However, the proprietary blend structure prevents consumers and clinicians from verifying whether individual ingredient doses reach the thresholds used in published clinical studies. Independent consumer feedback corroborates this concern, with users noting the proprietary blend limits their ability to assess individual ingredient dosages. Additionally, the manufacturer reports a customer satisfaction rating of 4.92 out of 5, while independent feedback channels present a more mixed picture — a pattern the editorial team flags as a potential marketing-reality gap. The brand-reported rating appears collected through brand-affiliated channels rather than independently verified platforms. Ingredient inconsistencies between main sales pages and FAQ sections have also been reported by consumers, which warrants additional scrutiny.
Ingredient Evidence and Dose Analysis
Alpha-Lipoic Acid (ALA) has substantial research support for peripheral neuropathy, particularly diabetic neuropathy. Clinical trials have used doses of 600 mg per day, with some studies using 300-1800 mg. The NATHAN 1 trial and SYDNEY 2 trial demonstrated meaningful symptom improvement at 600 mg daily. Without knowing Presgera's ALA dose, readers cannot determine whether the amount reaches these clinical thresholds.
Coenzyme Q10 (CoQ10) is an essential cofactor in mitochondrial energy production and functions as an antioxidant. Research on CoQ10 for neuropathy is more limited than for ALA, with most evidence focused on its role in statin-related myopathy rather than nerve-specific outcomes. Clinical studies typically use 100-300 mg daily. CoQ10's inclusion is scientifically reasonable, though the evidence for nerve-specific outcomes is preliminary compared to ALA.
Magnesium Glycinate supports nerve impulse transmission and muscle-nerve function. The glycinate form offers superior bioavailability compared to oxide or citrate forms. Clinical relevance for neuropathy is supported primarily by observational data linking magnesium deficiency to neuropathic symptoms rather than by interventional RCTs specifically for neuropathy treatment. Typical supplemental doses range from 200-400 mg elemental magnesium.
Cardiac Safety Profile
This is the section that differentiates UTCTS coverage from general wellness reviews. Each key ingredient carries specific interaction considerations for cardiac patients:
- CoQ10 and Warfarin: CoQ10 is structurally similar to vitamin K2 and may reduce the anticoagulant effectiveness of warfarin. Patients on warfarin should have INR monitored closely if adding CoQ10 supplementation. This interaction is well-documented in pharmacological literature.
- CoQ10 and Antihypertensives: CoQ10 may modestly lower blood pressure. Combined with ACE inhibitors, ARBs, calcium channel blockers, or beta-blockers, this additive effect could cause hypotension. Blood pressure monitoring is advisable.
- ALA and Blood Sugar Medications: ALA may lower blood glucose levels. Patients taking metformin, sulfonylureas, or insulin — commonly prescribed alongside cardiovascular medications in diabetic patients — should monitor for hypoglycemia. Dose adjustments may be necessary.
- Magnesium and Cardiac Medications: Magnesium can interact with digoxin (reduced absorption), certain antibiotics, and bisphosphonates. Magnesium supplementation in patients with renal impairment — common in heart failure — requires medical supervision due to accumulation risk.
- ALA and Thyroid Medications: ALA may interfere with levothyroxine absorption. Hypothyroidism is common in cardiac patients and medication timing should be separated.
The proprietary blend format compounds these concerns because clinicians cannot calculate interaction risk without knowing exact ingredient quantities. Patients on multiple cardiac medications should present the full product label to their prescribing physician or pharmacist before use.
User-Reported Outcomes
Independent user feedback is mixed. Some consumers report noticeable relief from tingling, numbness, and nerve discomfort within several weeks, while others describe minimal changes despite consistent use. Most users report best outcomes when combining Presgera with professional medical care, physical therapy, and blood sugar management rather than using it as a standalone approach. The timeline for meaningful improvements ranges from one week to six months in user reports, reflecting significant individual variability. The total volume of independently verified reviews remains modest compared to more established nerve supplements.
Pricing and Refund Terms
Presgera is available through the manufacturer's official website. The most commonly referenced price is approximately $49 per bottle on the six-bottle purchase plan, with single bottles available at higher per-unit cost. Bulk packages offer significant per-bottle discounts designed to encourage long-term use. The manufacturer provides a 60-day money-back guarantee on the most recent order. Specific refund procedures, including whether opened bottles qualify, should be confirmed with the retailer before purchasing. Pricing is subject to change. Verify current pricing on the manufacturer's official listing.
Buyer Takeaway
Presgera contains ingredients with genuine research support for nerve health — ALA in particular has meaningful clinical evidence for diabetic neuropathy at adequate doses. However, the proprietary blend prevents dose verification, and the brand-reported satisfaction rating may overstate independent user satisfaction. For cardiac patients, the CoQ10-warfarin interaction and ALA-blood sugar interaction deserve specific clinical attention. Individuals managing cardiovascular conditions alongside neuropathy should discuss this supplement with their cardiologist or pharmacist before use, presenting the full ingredient label. Readers who are not on cardiac medications and have confirmed the product aligns with their physician's guidance may find Presgera worth evaluating within the 60-day refund window. The supplement is not a substitute for medical evaluation or treatment of diagnosed neuropathy.
Related Reading
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes only and does not constitute medical advice. Results vary by individual. Consult your physician before starting any supplement, particularly if you take cardiovascular or metabolic medications.
Related reading: Memocept Review 2026: Cognitive Supplement Cardiac Safety Evaluated